Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.
NCT00343551
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
654
Enrollment
INDUSTRY
Sponsor class
Conditions
Essential Hypertension
Interventions
DRUG:
Aliskiren
Sponsor
Novartis